OraSure Technologies Awarded $8.6M BARDA Contract for Next-Gen Ebola Test
The firm will update its Ebola rapid antigen test that was authorized by the US Food and Drug Administration in 2019.
The test measures changes in wavelength to quantify the presence of disease in a patient sample in about 40 minutes.
Mologic Awarded £1M to Develop POC Test for SARS-CoV-2
The company is working with the Institut Pasteur de Dakar to validate and manufacture the test at a new manufacturing site in DiaTropix, Senegal.
Mologic, Institut Pasteur de Dakar to Develop Ebola Rapid Diagnostic Test
The partners are validating three rapid diagnostic test prototypes prior to initiating a trial in the Democratic Republic of the Congo during March 2020.
OraSure Technologies Rapid Ebola Test Granted Marketing Authorization by FDA
The test, which detects antibodies to Ebola virus from whole-blood samples and cadaveric oral fluid, was also granted breakthrough device designation.
Dec 18, 2018
Aug 29, 2018
Jul 30, 2018
Mar 16, 2017
Jun 5, 2015